Mid-year venture capital trends and the new deal pacing reality
Mid year is no longer a quiet checkpoint for venture capital. As mid-year venture capital trends crystallise, deal activity in early stage and late stage rounds is tracking sharply above the previous half year, with AI infrastructure and model companies pulling capital away from slower sectors. For a CEO, the signal is clear and unforgiving.
Global venture capital investment in the first half year is on pace to exceed the prior year by more than 60 percent, driven by a handful of very large AI deals that reshape both private markets and the adjacent public market narrative. PitchBook and CB Insights data on 2024 H1 fundraising (as of June 30, 2024) highlight how megadeals such as xAI’s roughly $6 billion Series B announced in May 2024, Anthropic’s multi-tranche rounds totalling more than $7 billion across strategic investors between late 2023 and April 2024, and CoreWeave’s late stage financings above $1 billion each in March and May 2024 have concentrated capital into a small set of AI leaders. That concentration means many startups and portfolio companies feel a booming headline market while their own deal flow and growth capital options remain constrained, especially where interest rates and unit economics still look fragile. You cannot read this article as a spectator; you are competing directly with those AI megadeals for attention, capital, and board bandwidth.
Behind the headlines, investors are segmenting the private market into three distinct lanes that matter for your strategy. First, early stage venture capital funds are still deploying dry powder into pre product teams, but with smaller min check sizes and more structured private investments to protect downside. Second, late stage capital private pools are behaving more like private equity and private credit hybrids, demanding clear paths to ipo or secondary liquidity before leading any large deal. Third, crossover funds that once bridged private markets and public markets are selectively returning, but only for companies with defensible gross margins and long term category leadership.
Where the money actually goes: sector heat map and investor behavior
Sector rotation defines mid-year venture capital dynamics more than any single macro headline. AI infrastructure, defense technology, climate software, and life sciences platforms are attracting the bulk of new capital, while consumer marketplaces and ad tech companies remain underweighted in most portfolio companies. For founders and CEOs, the question is not whether markets are open, but whether your narrative fits the current heat map.
In AI, investors are concentrating investment into a narrow set of infrastructure startups, often backing repeat founders with prior ipo outcomes or deep research pedigrees. Defense technology and dual use companies see strong support from specialist venture funds and some private equity managers, who add structured credit lines to extend runway and reduce dilution. In life sciences, large crossover rounds are returning as an asset class of their own, with biotech specialists treating late stage private investments almost like public market blocks, as analysed in this biotech venture deep dive on large rounds. A concrete illustration comes from Watershed, which raised a $150 million Series C for a climate software platform in February 2024 by pairing a clear decarbonisation thesis with disciplined unit economics and a credible path to public markets, showing how targeted positioning can still unlock substantial growth capital.
Gender lens and sector specialist funds such as Avestria and SteelSky Capital, both women’s health focused managers, illustrate how focused strategies can still raise capital and lead competitive deals in a tougher market. Their evolution into strategic leaders in women’s health and related life sciences shows how a managing director with a sharp thesis can turn constrained private markets into an advantage, as explored in this analysis of a specialist venture capital firm emerging as a strategic leader in venture capital. For your own company, the takeaway is simple; align your story with a clear market wedge, show how your growth profile matches current investor appetite, and be explicit about how you will use both equity and credit to reach the next value inflection.
LP allocation shifts, term sheets, and the new cost of capital
Mid-year venture capital trends are being shaped upstream by limited partners, not just by GPs. Endowments are in repair mode and slowing commitments to both private equity and venture capital, while sovereign wealth funds and large family offices quietly increase allocations to selected private markets managers. That shift changes who ultimately prices your round and how aggressively they negotiate terms.
With interest rates still elevated relative to the prior cycle, the cost of capital in private investments has structurally reset. Many managing directors now treat growth equity and late stage venture as a single blended asset class, toggling between structured equity, convertible credit, and minority private equity style deals. For CEOs, that means a Series B or C term sheet can look more like a private credit instrument than a classic venture deal, especially when investors remain wary of a choppy ipo window.
On the ground, the marginal Series A term sheet in June is meaningfully different from what you saw in January. Liquidation preferences are cleaner, but investors often add performance based milestones and tighter covenants around secondary sales by founders and early employees. In parallel, institutional allocators are using tools such as equity derivatives and structured secondaries to manage exposure across public markets and private markets, a trend analysed in depth in this piece on how institutional equity derivatives trading is reshaping strategic decision making.
Summer fundraising calendar: how CEOs should time and structure the next round
The summer calendar is where mid-year venture capital trends become operational for you. Historically, August has been a soft month for new investment decisions, but the rise of continuation vehicles and secondary funds now provides bridge capital for strong companies that time their raises poorly. Your task is to map deal activity, investor bandwidth, and your own cash runway with ruthless precision.
For early stage startups, the optimal window to launch a round often falls between late May and mid July, when partners still have committee capacity and are eager to lock in ownership before the half year closes. Late stage companies with meaningful revenue and clear paths to ipo or strategic exit can afford to run longer processes, but they must respect that many investors effectively pause new private investments during late August. In both cases, you should treat private credit lines, venture debt, and structured capital private instruments as tactical tools, not default solutions.
Practically, build a target list of 30 to 40 investors, with a clear split between traditional venture capital, growth equity, and crossover public market specialists. Run a tight two to three week min window for first meetings, then compress partner discussions so your deal does not drift into the August dead zone. The CEOs who win this half year are those who treat capital as a strategic weapon, align their markets narrative with where allocators are actually moving, and remember that what matters is not the term sheet, but the power it encodes.
FAQ: mid-year venture capital trends for CEOs
How are mid-year venture capital trends affecting early stage fundraising?
Early stage fundraising remains active, but investors are more selective and structured. Seed and Series A funds still deploy dry powder, yet they demand clearer paths to product market fit and more disciplined use of equity capital. Expect smaller rounds, more emphasis on private credit or revenue based financing as complements, and tighter oversight of portfolio companies.
What sectors are currently attracting the most venture capital at mid year?
AI infrastructure, defense technology, climate solutions, and life sciences platforms are drawing the largest share of new investment. These sectors align with long term structural trends and can support both private market and eventual public market outcomes. Founders outside these areas must show sharper differentiation and stronger growth metrics to compete for capital.
How should a CEO time a growth round around the summer slowdown?
For most companies, the best time to launch a growth round is late spring or very early summer, aiming to secure term sheets before August. Investors often reduce new deal activity during late August, focusing instead on existing portfolio companies and internal planning. If timing slips, consider bridge capital or private credit options to extend runway into the next active window.
What changes should I expect in term sheets compared with earlier in the year?
Term sheets now reflect a higher cost of capital and more risk management by investors. You may see cleaner liquidation preferences but more performance based milestones, tighter covenants, and increased scrutiny of secondary sales by founders. Late stage deals in particular can resemble private equity or hybrid private credit structures rather than traditional venture rounds.
How do LP allocation shifts influence my company’s ability to raise capital?
When endowments slow commitments and sovereign wealth funds or family offices step in, the mix of capital behind your investors changes. That mix influences fund pacing, risk appetite, and the types of deals GPs prioritise in their private markets portfolios. Understanding which LPs back your target funds helps you anticipate whether they will lean into new investments this half year or focus on supporting existing portfolio companies.